Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC)
Familial Cancer · 2024-08 · 23 (3) · 221-232
DOI: 10.1007/s10689-024-00372-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Familial Cancer, online erschienen am 04.04.2024. Verfasst von Michelle F Jacobs und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetic Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Genetic Predisposition to Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 119 Literaturangaben.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is often diagnosed at an advanced stage, resulting in poor prognosis and low 5-year survival rates. While early evidence suggests increased long-term survival in those with screen-detected resectable cancers, surveillance imaging is currently only recommended for individuals with a lifetime risk of PDAC ≥ 5%. Identification of risk factors for PDAC provides opportunities for early detection, risk reducing interventions, and targeted therapies, thus potentially improving patient outcomes. Here, we summarize modifiable and non-modifiable risk factors for PDAC. We review hereditary cancer syndromes associated with risk for PDAC and their implications for patients and their relatives. In addition, other biologically relevant pathways and environmental and lifestyle risk factors are discussed. Future work may focus on elucidating additional genetic, environmental, and lifestyle risk factors that may modify PDAC risk to continue to identify individuals at increased risk for PDAC who may benefit from surveillance and risk reducing interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Genetic Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA. estoffel@med.umich.edu.
ORCID-Profile: Michelle F Jacobs, Elena M Stoffel
Zitieren
APA
Jacobs, M. F., & Stoffel, E. M. (2024). Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC). Familial Cancer, 23(3), 221-232. https://doi.org/10.1007/s10689-024-00372-5
Vancouver
Jacobs MF, Stoffel EM. Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC). Familial Cancer. 2024;23(3):221-232. doi:10.1007/s10689-024-00372-5
BibTeX
@article{Jacobs2024,
author = {Jacobs, Michelle F and Stoffel, Elena M},
title = {Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC)},
journal = {Familial Cancer},
year = {2024},
volume = {23},
number = {3},
pages = {221--232},
doi = {10.1007/s10689-024-00372-5}
}
EUVIMED